Literature DB >> 2215589

Acute fatal leukoencephalopathy after interleukin-2 therapy.

C J Vecht, C Keohane, R S Menon, C J Punt, G Stoter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2215589     DOI： 10.1056/nejm199010183231616

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.

Authors:  Ruth Whittington; Diana Faulds
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

2.  Neurotoxicity of antitumoral IL-2 therapy: evoked cognitive potentials and brain mapping.

Authors:  A Pace; A Pietrangeli; L Bove; M Rosselli; M Lopez; B Jandolo
Journal:  Ital J Neurol Sci       Date:  1994-10

Review 3.  New aspects of immunotherapy of leptomeningeal metastasis.

Authors:  U Herrlinger; M Weller; M Schabet
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

4.  In vivo relationship of interleukin-2 and soluble IL-2 receptor to blood-brain barrier impairment in patients with active multiple sclerosis.

Authors:  M K Sharief; R Hentges; M Ciardi; E J Thompson
Journal:  J Neurol       Date:  1993-01       Impact factor: 4.849

Review 5.  Clinical toxicity of interleukin-2.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

Review 6.  History and current state of immunotherapy in glioma and brain metastasis.

Authors:  Tresa McGranahan; Gordon Li; Seema Nagpal
Journal:  Ther Adv Med Oncol       Date:  2017-02-01       Impact factor: 8.168

Review 7.  Glioblastoma Treatment Modalities besides Surgery.

Authors:  Hao Zhang; Ruizhe Wang; Yuanqiang Yu; Jinfang Liu; Tianmeng Luo; Fan Fan
Journal:  J Cancer       Date:  2019-08-27       Impact factor: 4.207
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.